Dingli Xu
Impact in
-
- Blood Pressure and Hypertension Studies
- Cardiac Valve Diseases and Treatments
- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management
- Nephrology top 2%
Papers in
-
- Cardiac Valve Diseases and Treatments 15
- Cardiovascular Function and Risk Factors 11
- Heart Failure Treatment and Management 10
- Blood Pressure and Hypertension Studies 7
- Cardiac Fibrosis and Remodeling 6
- Atrial Fibrillation Management and Outcomes 6
- Co-authors
- Qingchun Zeng (68 shared papers)Hao Ren (29 shared papers)Wenyan Lai (33 shared papers)Weiyi Mai (5 shared papers)Qiong Zhan (31 shared papers)Xianzhong Meng (12 shared papers)Zuheng Liu (13 shared papers)Sheng Wang (4 shared papers)
- Journals
- Frontiers in Cardiovascular Medicine (8 papers)PLoS ONE (5 papers)Cardiovascular Research (4 papers)Clinical Cardiology (4 papers)Molecular Medicine (4 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Dingli Xu
156 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 141
- Cardiology and Cardiovascular Medicine 1.2k
- Nephrology 210
- Geriatrics and Gerontology 70
- Hepatology 155
- Pharmacology 163
Countries citing papers authored by Dingli Xu
This map shows the geographic impact of Dingli Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dingli Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dingli Xu more than expected).
Fields of papers citing papers by Dingli Xu
This network shows the impact of papers produced by Dingli Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dingli Xu. The network helps show where Dingli Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Dingli Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 164 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 238 | |
| 2 | 2013 | 174 | |
| 3 | 1995 | 133 | |
| 4 | 2009 | 129 | |
| 5 | 2017 | 129 | |
| 6 | 2013 | 110 | |
| 7 | 2017 | 98 | |
| 8 | 2021 | 91 | |
| 9 | 1998 | 89 | |
| 10 | 1998 | 87 | |
| 11 | 2014 | 86 | |
| 12 | 2017 | 85 | |
| 13 | 2018 | 85 | |
| 14 | 2014 | 82 | |
| 15 | 2019 | 81 | |
| 16 | 2023 | 80 | |
| 17 | 2020 | 78 | |
| 18 | 2013 | 77 | |
| 19 | 2015 | 77 | |
| 20 | 2012 | 73 |
About Dingli Xu
Dingli Xu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Immunology, having authored 164 papers that have together received 4.0k indexed citations. Recurring topics across this work include Cardiac Valve Diseases and Treatments (15 papers), Cardiovascular Function and Risk Factors (11 papers), Heart Failure Treatment and Management (10 papers), Blood Pressure and Hypertension Studies (7 papers), Cancer-related molecular mechanisms research (6 papers), Cardiac Fibrosis and Remodeling (6 papers), Advanced Glycation End Products research (6 papers) and Atrial Fibrillation Management and Outcomes (6 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.2k citations), Nephrology (210 citations), Geriatrics and Gerontology (70 citations), Hepatology (155 citations) and Pharmacology (163 citations). Dingli Xu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Qingchun Zeng, Hao Ren, Wenyan Lai, Weiyi Mai, Qiong Zhan, Xianzhong Meng, Zuheng Liu, Sheng Wang, M. Ohara and Lihua Ao. Their work appears in journals such as Frontiers in Cardiovascular Medicine, PLoS ONE, Cardiovascular Research, Clinical Cardiology and Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.